Corcept Therapeutics (CORT) Return on Invested Capital (2017 - 2026)

Corcept Therapeutics' Return on Invested Capital history runs 10 years deep, the most recent figure standing at 0.0% for Q1 2026.

• In Q1 2026, Return on Invested Capital changed 0.0% year-over-year to 0.0%; the TTM figure through Mar 2026 stood at 0.0% (changed 0.0% YoY), while the FY2025 annual figure was 0.0%, changed 0.0% from the prior year.
• Return on Invested Capital came in at 0.0% for Q1 2026 at Corcept Therapeutics, down from 0.0% in the prior quarter.
• In the past five years, Return on Invested Capital ranged from a high of 0.0% in Q1 2022 to a low of 0.0% in Q1 2026.
• A 5-year average of 0.0% and a median of 0.0% in 2024 frame the typical range for Return on Invested Capital.
• On a YoY basis, Return on Invested Capital climbed as much as 0 bps in 2022 and fell as far as 0 bps in 2022.
• Corcept Therapeutics' Return on Invested Capital stood at 0.0% in 2022, then slipped by 6 bps to 0.0% in 2023, then retreated by 4 bps to 0.0% in 2024, then slumped by 42 bps to 0.0% in 2025, then sank by 148 bps to 0.0% in 2026.
• According to Business Quant data, Return on Invested Capital over the past three periods registered 0.0%, 0.0%, and 0.0% for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison